Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) delivered a profit and met Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company. Shares are up 4.17%.
Cumberland Pharmaceuticals, Inc. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share increased 150% to $0.05 in the quarter versus EPS of $0.02 in the year-earlier quarter.
Revenue: Rose 0.39% to $10.3 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: Cumberland Pharmaceuticals, Inc. reported adjusted EPS income of $0.05 per share. By that measure, the company met the mean analyst estimate of $0.05. It beat the average revenue estimate of $10 million.
Quoting Management: “Our progress during the first quarter included top line results from three new Caldolor studies and new international partnerships for India and Indonesia,” said A.J. Kazimi, Chief Executive Officer of Cumberland Pharmaceuticals. “We were also pleased with the first quarter financial results maintaining revenues from the prior year quarter, while significantly increasing our net income through the efficient management of our expenses.”
Key Stats (on next page)…
Revenue decreased 24.82% from $13.7 million in the previous quarter. EPS decreased 58.33% from $0.12 in the previous quarter.
Looking Forward: Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $0.08 to a profit $0.06. For the current year, the average estimate has moved down from a profit of $0.26 to a profit of $0.23 over the last ninety days.
Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)